Literature DB >> 6968234

The fractionation, characterization, and subcellular localization of colony-stimulating activities released by the human monocyte-like cell line, GCT.

J F DiPersio, J K Brennan, M A Lichtman, C N Abboud, F H Kirkpatrick.   

Abstract

GCT, a human monocyte-like cell line, has been shown to release biochemically distinct colony-stimulating activities (CSAs) for mouse and human marrows. These appear to be periodate-sensitive proteins with critical disulfide bonds. One, of molecular weight 145,000 daltons, stimulates macrophagic colony growth and is related to a 30,000-dalton molecule that also stimulates mouse growth. A 30,000-dalton CSA for human marrow can be separated from the 30,000-dalton mouse CSA by isoelectric focusing and gradient polyacrylamide gel electrophoresis. This distinction agrees with our previous finding of differential neutralization with anti-human urinary CSF antibody. The 30,000-dalton CSAs stimulate neutrophil, neutrophil-monocyte, and eosinophil colony growth in human marrow but only neutrophil and neutrophil-monocyte colonies in the mouse. Subcellular fractionation of GCT cells indicates that there are pools of preformed CSAs primarily associated with the cell cytosol that have similar apparent molecular weights to their secreted counterparts.

Entities:  

Mesh:

Substances:

Year:  1980        PMID: 6968234

Source DB:  PubMed          Journal:  Blood        ISSN: 0006-4971            Impact factor:   22.113


  14 in total

1.  Simple method for granulocyte-macrophage cell culture and staining in soft agar: comparison with a standard research technique.

Authors:  K Hyde; A J Steed; H Lenehan; M J Saunders; J T Richards; J A Lin Yin; C G Geary
Journal:  J Clin Pathol       Date:  1989-12       Impact factor: 3.411

2.  In vitro hemopoiesis in human micro long-term bone marrow cultures recharged with either allogeneic, T-cell-depleted allogeneic, or syngeneic bone marrow cells.

Authors:  H G Mergenthaler; P Dörmer
Journal:  Blut       Date:  1990-04

3.  Inhibitory effect of a human T cell hybrid factor on both cell growth and mixed lymphocyte reactivity. Correlation with class II molecule expression.

Authors:  M Trucco; S Shaw; R Korngold
Journal:  J Clin Invest       Date:  1985-09       Impact factor: 14.808

4.  HLA-DR human histocompatibility leukocyte antigens-restricted lymphocyte-monocyte interactions in the release from monocytes of acidic isoferritins that suppress hematopoietic progenitor cells.

Authors:  H E Broxmeyer; L Juliano; L Lu; E Platzer; B Dupont
Journal:  J Clin Invest       Date:  1984-04       Impact factor: 14.808

5.  Thromboplastin (tissue factor) in plasma membranes of human monocytes.

Authors:  O Hetland; A B Brovold; R Holme; G Gaudernack; H Prydz
Journal:  Biochem J       Date:  1985-06-15       Impact factor: 3.857

6.  Effects of human alpha-interferon on granulocyte-macrophage progenitor cells (CFU-GM) in vitro.

Authors:  J S Schwamborn; R M Nickels; B D Katthagen; H W Pees; P G Scheurlen
Journal:  Blut       Date:  1988-03

7.  Comparative in vitro toxicity of mitoxantrone and adriamycin in human granulocyte-macrophage progenitor cells.

Authors:  H G Mergenthaler; P Brühl; G Ehninger; E Heidemann
Journal:  Cancer Chemother Pharmacol       Date:  1987       Impact factor: 3.333

8.  Clonogenic growth of acute non-lymphocytic leukemia cells in serum-free medium.

Authors:  P A Bernabei; V Santini; O Dal Pozzo; R Bezzini; V Gattei; R Saccardi; G Rombolà; P R Ferrini
Journal:  Experientia       Date:  1988-10-15

9.  Dependence of highly enriched human bone marrow progenitors on hemopoietic growth factors and their response to recombinant erythropoietin.

Authors:  C A Sieff; S G Emerson; A Mufson; T G Gesner; D G Nathan
Journal:  J Clin Invest       Date:  1986-01       Impact factor: 14.808

10.  Relationship of cell-cycle expression of Ia-like antigenic determinants on normal and leukemia human granulocyte-macrophage progenitor cells to regulation in vitro by acidic isoferritins.

Authors:  H E Broxmeyer
Journal:  J Clin Invest       Date:  1982-03       Impact factor: 14.808

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.